Robert Lorne Abel - Sep 13, 2021 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
EVP, Chief Computational Scientist, Head of Modeling R&D
Signature
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel
Stock symbol
SDGR
Transactions as of
Sep 13, 2021
Transactions value $
-$698,201
Form type
4
Date filed
9/14/2021, 05:00 PM
Previous filing
Jun 22, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SDGR Common Stock Options Exercise $265K +15.6K $17.00 15.6K Sep 13, 2021 Direct F1
transaction SDGR Common Stock Sale -$356K -5.82K -37.3% $61.09 9.78K Sep 13, 2021 Direct F1, F2
transaction SDGR Common Stock Sale -$608K -9.78K -100% $62.14 0 Sep 13, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Options Exercise $0 -15.6K -12.39% $0.00 110K Sep 13, 2021 Common Stock 15.6K $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.65 to $61.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.73 to $62.63, inclusive.
F4 This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

Remarks:

EVP, Chief Computational Scientist, Head of Modeling R&D